AstraZeneca's Enhertu gets regulatory approval in India for first-line HER2-positive breast cancerAstraZeneca Pharma India has secured approval from India's drug regulator for its smart chemotherapy drug Enhertu. This allows for its impo...
Asian stocks fall, oil gains as US strikes IranUS forces launched fresh strikes on Iran, escalating geopolitical risks and sending oil prices up over 2%. This development, coupled with a...
Government may lift price cap on cancer drugs making them costlier by up to 50%India's government is taking emergency steps to ensure cancer patients get vital drugs. Cisplatin and carboplatin, crucial chemotherapy age...
Hetero partners with Richter to develop, market Semaglutide injection globallyHyderabad's Hetero Labs partners with European giant Gedeon Richter. They will jointly develop and sell Semaglutide Injection, the generic ...
RBI "opens the floodgates": Dhawal Dalal on why now may be the best entry point for debt investors in two yearsIndia is attracting foreign debt capital by removing taxes and easing borrowing rules. This move is expected to inject significant liquidit...
Bharathiraja: A towering titan who injected raw, rural realism into Tamil cinemaRenowned filmmaker P Bharathiraja passed away at 84. He transformed Tamil cinema by bringing rural realism to the screen. Bharathiraja was ...
Messi magic returns in Argentina's 3-0 win over Iceland in World Cup warm-upLionel Messi's return from injury saw Argentina triumph 3-0 over Iceland in their World Cup warm-up. Despite starting on the bench, Messi's...
India’s anti-obesity drug market sees slower growth after initial surge in generic semaglutide salesIndia's anti-obesity drug market sees a slowdown after initial generic semaglutide sales. Demand has eased from its peak, with growth moder...
US stocks: Lilly shares rise on hopes that next-gen drug will extend lead in weight-loss marketLilly presented full data from two retatrutide trials, one in treatment naive type 2 diabetes patients and another in patients with obesity...
OpenAI rolls out Lockdown Mode for users handling sensitive informationOpenAI has launched Lockdown Mode to combat prompt injection attacks, a security feature designed for users handling sensitive data. This m...
Eli Lilly says next-gen obesity drug curbs sleep apnea, among other benefitsEli Lilly presented trial results for its new obesity drug retatrutide. The drug significantly reduced sleep apnea severity and knee osteoa...
In 1987, ophthalmologist Dr. Jean Carruthers noticed her crossed-eye patients' frown lines were vanishing, and Botox accidentally became cosmetic history's biggest hitOriginally developed to address eye disorders such as blepharospasm, Botox has evolved into a key player in the cosmetic industry since its...
Small packs make big gains as budgets shrink and costs riseWith inflation on the rise, Indian shoppers are favoring compact product packaging. This shift not only reflects changing consumer habits b...
FIFA WC 2026 set to be a free kick for tourism, retail and clothing industryAnalysts said U.S. hotel operators Marriott, Hilton and Hyatt as well as online travel platforms Airbnb, Booking Holdings and Expedia are p...
PixelSky invests Rs 40-45 crore in biofuels firm GPS RenewablesPixelSky Capital, backed by IndigoEdge and Yumlane founder Hitesh Ahuja, has invested Rs 40-45 crore in waste-to-energy firm GPS Renewables...
Zydus Semaglutide approval: Delhi HC directs CDSCO to decide on patient safety concernsThe Delhi High Court has asked the Central Drugs Standard Control Organisation to review a petition challenging Zydus Lifesciences' approva...
Bio Medica Laboratories shares to debut today. Here's what GMP suggests ahead of listingBio Medica Laboratories' shares are set to list on the NSE SME platform amidst weak grey market sentiment, with the IPO currently trading a...